- €712.39m
- €715.48m
- €131.69m
Brief: Pharmanutra Prelim. FY Revenue At EUR 115.4 Mln
Brief: Pharmanutra Signs Distribution Deal For Sideral Products In Canada
Brief: Pharmanutra 9M Net Profit EUR 13.2 Mln
Brief: Pharmanutra Signs Agreement With Consulting Firm For U.S. Development Plan
Brief: Pharmanutra H1 EBITDA Up 15.3% To EUR 16.2 Mln
Brief: Pharmanutra Q1 Net Profit Down To EUR 2.6 Mln
Brief: PharmaNutra Fy Net Profit Down To EUR 12.8 Mln
Brief: Pharmanutra Approves Merger By Incorporation Of Units Junia Pharma, Alesco Into Pharmanutra
Brief: Pharmanutra FY Consolidated Revenues Up To EUR 100.2 Mln
Brief: Pharmanutra 9-Month Net Profit Down To EUR 11.7 Mln
Brief: Pharmanutra H1 Net Profit Down To EUR 7.2 Mln
Brief: Pharmanutra Q1 Net Profit Up To EUR 5.4 Mln
Brief: Pharmanutra Signs Three Distribution Deals For SiderAl Product Line
Brief: Pharmanutra FY Net Profit Up To EUR 15.0 Mln
Brief: Pharmanutra Sees 2022-2030 CAGR Revenue Growth Of 10.9%
Brief: PharmaNutra, Ferrari Sign Partnership For FIA World Endurance Championship
Brief: Pharmanutra Signs Three Agreements For Distribution In Indonesia, Kuwait And Mexico
Brief: Pharmanutra Establishes Subsidiary In The U.S.
Brief: Pharmanutra 9-Month Net Profit Up To EUR 12.8 Mln